DCCPS-funded research focuses on defining factors that influence cancer risk and prognosis, as well as integrating evidence-based interventions into practice and tracking outcomes. Cancer outcomes research has expanded to include not only traditional biomedical outcomes but also health-related quality of life, patient experiences of care, and economic burden. Researchers are examining variations in the patterns and quality of cancer care. They also are exploring the use of precision tools to measure factors affecting health disparities and to develop targeted interventions for both large populations and individual patients.
Areas of Research
Research is needed to more clearly understand how factors related to energy balance—the integrated effects of diet, physical activity, and genetics on growth and body weight—interact over a lifetime to influence cancer risk and prognosis.
Transdisciplinary research teams are delineating factors that contribute to health disparities and barriers in care for specific populations. Effective interventions will require new or adapted measures on inequity, social environment, and social determinants of health.
Research is needed to optimize various processes of care, including communication and coordination across the cancer control continuum, and to evaluate how these processes affect health outcomes.
Patterns of Care
Researchers are examining variations in the patterns and quality of care delivered in diverse health care settings, identifying populations at risk for receiving suboptimal care, and examining factors influencing disparities in the delivery of effective and timely care.
Precision Medicine & Population Health
Precision tools are needed not only for medical applications but also to measure biological, social, environmental, and economic factors affecting health in populations. These tools also can aid in developing more precise, targeted interventions for specific populations and individual patients.
Hereditary Cancer Syndromes
Genetic testing can identify individuals with hereditary cancer syndromes who may benefit from specialized prevention, screening, or treatment. Identifying these individuals also may help guide the future medical care of their relatives and enable smaller, faster medical trials and research studies.